Avails Medical’s eQUANT paper ‘Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing’ published in Scientific Reports
MENLO PARK, Calif., June 1, 2021 /PRNewswire/ – Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (AST) announced today the publication of a new peer-reviewed paper…
Read More
Avails Medical awarded $2.5M in CARB-X funding for the development of its rapid antibiotic susceptibility testing device to identify the most effective antibiotic therapy
MENLO PARK, Calif., February 1, 2021 /PRNewswire/ -- Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (AST) announced today it was awarded up to $2.5M in…
Read More
Avails Medical, a pioneer in automated, accelerated antibiotic susceptibility testing for septic patients announced today the participation of OMRON VENTURES Co., Ltd. in its current equity financing round
MENLO PARK, Calif., March 24, 2020 /PRNewswire/ -- Avails Medical, a pioneer in automated, accelerated antibiotic susceptibility testing (AST) for septic patients announced today the participation of OMRON VENTURES Co., Ltd. in…
Read More
Avails Medical announcing eQuant, a novel IVD being developed to allow rapid standardized inoculum generation directly from a positive blood culture
Product integrates to non-rapid commercial AST, antibiotic susceptibility test, systems and dramatically shortens the process. Menlo Park, Calif., Apr. 11th, 2019 (PRESS RELEASE) -- Avails Medical, Inc. (www.availsmedical.com), an in-vitro…
Read More
EVENTS
2021 Events Coming Soon
Scheduling for conferences in 2021.
MEDIA
Recent Posts / View All Posts
Hightech oder Hoelle Leben im Silicon Valley Avails has been featured on German TV (VOX) documentary about the Silicon Valley
